Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $8.53 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 42.38.
Market Cap
8.53T
Revenue
4.59T
Profits
201.21B
PE Ratio
42.38
Profit Margin
4.39%
Dividend Yield
0.42%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.02T | -1.13% | 772,858 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 576.55B | 0.50% | 1,666,626 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 397.32B | 0.05% | 1,115,296 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.90B | 0.71% | 2,156,059 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 297.44B | -0.27% | 2,418,163 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 280.97B | -0.91% | 901,762 | 60.44B |
| 7 | NVS | Novartis AG | 278.13B | -0.31% | 516,631 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 193.08B | 1.00% | 7,730,434 | 50.57B |
| 9 | AMGN | Amgen Inc. | 191.66B | 0.30% | 659,965 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 176.07B | -0.39% | 350,462 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 154.64B | -1.05% | 1,444,501 | 29.74B |
| 12 | ABT | Abbott Laboratories | 153.23B | -1.87% | 4,237,153 | 45.13B |
| 13 | PFE | Pfizer Inc. | 149.44B | 0.19% | 12,339,983 | 63.32B |
| 14 | ISRG | Intuitive Surgical, Inc. | 144.23B | -1.37% | 584,346 | 10.58B |
| 15 | CVS | CVS Health Corporation | 130.64B | 1.90% | 2,660,348 | 405.62B |
| 16 | DHR | Danaher Corporation | 128.51B | 0.43% | 875,532 | 24.78B |
| 17 | SYK | Stryker Corporation | 118.78B | 1.37% | 1,027,465 | 25.27B |
| 18 | BMY | Bristol-Myers Squibb Company | 116.75B | 0.47% | 2,174,784 | 48.48B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.36B | -0.52% | 290,558 | 12.22B |
| 20 | SNY | Sanofi | 105.53B | 0.59% | 858,801 | 54.60B |
| 21 | GSK | GSK plc | 104.52B | 0.72% | 1,753,821 | 43.29B |
| 22 | MDT | Medtronic plc | 102.94B | -0.19% | 2,278,531 | 36.36B |
| 23 | MCK | McKesson Corporation | 94.93B | 0.33% | 143,229 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 86.67B | -0.02% | 577,516 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 85.51B | 1.83% | 405,204 | 76.39B |
| 26 | CI | The Cigna Group | 78.84B | 1.09% | 221,401 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 68.94B | -1.67% | 5,888,155 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 62.20B | -0.01% | 205,378 | 14.92B |
| 29 | ARGX | argenx SE | 55.58B | 0.94% | 142,654 | 4.74B |
| 30 | COR | Cencora, Inc. | 54.48B | -0.53% | 242,183 | 328.68B |
| 31 | CAH | Cardinal Health, Inc. | 52.23B | 0.83% | 568,350 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 50.03B | 0.63% | 915,636 | 28.34B |
| 33 | EW | Edwards Lifesciences Corporation | 48.86B | -1.06% | 1,323,896 | 6.30B |
| 34 | MDLN | Medline Inc. | 47.57B | -2.48% | 5,418,591 | 29.14B |
| 35 | HUM | Humana Inc. | 44.96B | 1.58% | 212,425 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.02B | 0.03% | 111,452 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 40.23B | -0.91% | 612,413 | 22.23B |
| 38 | TEVA | Teva Pharmaceutical Industries Limited | 39.66B | -1.45% | 1,246,574 | 17.35B |
| 39 | HLN | Haleon plc | 39.48B | 1.00% | 4,754,364 | 14.85B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.47B | -0.43% | 418,745 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 36.40B | -0.52% | 268,201 | 7.23B |
| 42 | WAT | Waters Corporation | 35.20B | -0.35% | 208,817 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.78B | -1.01% | 1,826,047 | 9.53B |
| 44 | RVMD | Revolution Medicines, Inc. | 32.70B | 3.06% | 493,783 | - |
| 45 | ALC | Alcon Inc. | 32.13B | 0.24% | 506,169 | 10.63B |
| 46 | CNC | Centene Corporation | 31.69B | 1.02% | 1,028,122 | 178.33B |
| 47 | RPRX | Royalty Pharma plc | 31.67B | -0.52% | 628,485 | 2.44B |
| 48 | NTRA | Natera, Inc. | 30.86B | -1.70% | 184,958 | 2.50B |
| 49 | IQV | IQVIA Holdings Inc. | 30.07B | -0.48% | 380,965 | 16.63B |
| 50 | BIIB | Biogen Inc. | 29.91B | 1.32% | 184,617 | 9.94B |
| 51 | ONC | BeOne Medicines AG | 29.54B | 2.07% | 90,696 | 5.70B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.40B | 0.20% | 892,768 | 20.98B |
| 53 | DXCM | DexCom, Inc. | 28.68B | -1.22% | 1,433,903 | 4.82B |
| 54 | RMD | ResMed Inc. | 28.12B | 1.20% | 349,659 | 5.54B |
| 55 | VEEV | Veeva Systems Inc. | 25.77B | -1.81% | 614,616 | 3.32B |
| 56 | ILMN | Illumina, Inc. | 24.49B | -2.60% | 512,248 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.44B | 0.96% | 530,793 | 20.34B |
| 58 | WST | West Pharmaceutical Services, Inc. | 23.27B | -0.28% | 101,329 | 3.22B |
| 59 | MTD | Mettler-Toledo International Inc. | 23.01B | -0.21% | 26,113 | 4.09B |
| 60 | UTHR | United Therapeutics Corporation | 22.93B | -0.96% | 84,598 | 3.17B |
| 61 | BNTX | BioNTech SE | 22.79B | 0.64% | 339,859 | 3.23B |
| 62 | DGX | Quest Diagnostics Incorporated | 22.61B | 0.22% | 94,069 | 11.28B |
| 63 | ROIV | Roivant Sciences Ltd. | 21.77B | 1.78% | 1,468,279 | 8.26M |
| 64 | LH | Labcorp Holdings Inc. | 21.73B | -0.08% | 97,506 | 14.14B |
| 65 | INCY | Incyte Corporation | 21.65B | 0.48% | 338,830 | 5.36B |
| 66 | INSM | Insmed Incorporated | 21.11B | 0.71% | 1,188,990 | 819.56M |
| 67 | STE | STERIS plc | 20.32B | 0.60% | 146,842 | 5.94B |
| 68 | MRNA | Moderna, Inc. | 20.25B | 2.82% | 1,727,081 | 2.23B |
| 69 | VTRS | Viatris Inc. | 19.10B | 0.55% | 1,569,766 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.41B | 0.29% | 469,017 | 1.08B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.05B | 1.16% | 389,818 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.16B | -1.24% | 386,861 | 3.10B |
| 73 | GMAB | Genmab A/S | 15.30B | -0.87% | 482,231 | 3.90B |
| 74 | THC | Tenet Healthcare Corporation | 15.19B | 1.83% | 252,453 | 21.46B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.56B | -1.74% | 155,829 | 4.44B |
| 76 | ASND | Ascendis Pharma A/S | 13.79B | 3.01% | 171,872 | 998.25M |
| 77 | SOLV | Solventum Corporation | 13.56B | -1.17% | 273,897 | 8.26B |
| 78 | DVA | DaVita Inc. | 13.53B | 3.38% | 282,209 | 13.84B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.43B | -1.01% | 69,335 | 2.68B |
| 80 | EXEL | Exelixis, Inc. | 13.42B | -0.22% | 348,955 | 2.38B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 13.32B | 0.67% | 384,734 | 579.96M |
| 82 | AXSM | Axsome Therapeutics, Inc. | 13.25B | 1.47% | 113,635 | 708.24M |
| 83 | COO | The Cooper Companies, Inc. | 13.15B | -0.10% | 401,373 | 4.23B |
| 84 | BTSG | BrightSpring Health Services, Inc. | 13.05B | -0.71% | 725,059 | 13.65B |
| 85 | SNN | Smith & Nephew plc | 12.86B | -0.47% | 311,045 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.58B | -0.49% | 99,171 | 4.10B |
| 87 | PEN | Penumbra, Inc. | 12.51B | -0.04% | 101,330 | 1.45B |
| 88 | ELAN | Elanco Animal Health Incorporated | 12.08B | 0.58% | 998,361 | 4.89B |
| 89 | IONS | Ionis Pharmaceuticals, Inc. | 12.05B | -1.19% | 422,374 | 1.06B |
| 90 | FMS | Fresenius Medical Care AG | 11.98B | 2.68% | 269,546 | 22.32B |
| 91 | RVTY | Revvity, Inc. | 11.19B | -1.18% | 316,835 | 2.90B |
| 92 | ICLR | ICON Public Limited Company | 11.18B | -2.63% | 232,057 | 8.25B |
| 93 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.13B | 1.76% | 54,284 | 1.13B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.08B | -0.15% | 381,670 | 3.58B |
| 95 | GMED | Globus Medical, Inc. | 10.90B | -0.27% | 302,786 | 3.10B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | 1.06% | 273,727 | 3.24B |
| 97 | BAX | Baxter International Inc. | 10.61B | 0.29% | 2,476,361 | 11.32B |
| 98 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.53B | 0.43% | 345,286 | 622.01M |
| 99 | MOH | Molina Healthcare, Inc. | 10.40B | 3.33% | 282,420 | 43.10B |
| 100 | PODD | Insulet Corporation | 10.32B | -0.12% | 249,376 | 2.90B |
| 101 | EHC | Encompass Health Corporation | 10.19B | 0.30% | 166,779 | 6.07B |
| 102 | SMMT | Summit Therapeutics Inc. | 10.16B | 0.11% | 1,468,050 | - |
| 103 | RGC | Regencell Bioscience Holdings Limited | 9.85B | 0.96% | 26,569 | - |
| 104 | NUVL | Nuvalent, Inc. | 9.73B | -0.19% | 3,975,616 | - |
| 105 | KRYS | Krystal Biotech, Inc. | 9.58B | 1.10% | 124,770 | 417.30M |
| 106 | CYTK | Cytokinetics, Incorporated | 9.57B | 1.71% | 280,652 | 105.82M |
| 107 | HSIC | Henry Schein, Inc. | 9.23B | 1.03% | 234,042 | 13.38B |
| 108 | CRL | Charles River Laboratories International, Inc. | 9.05B | -0.09% | 124,459 | 4.03B |
| 109 | CORT | Corcept Therapeutics Incorporated | 8.98B | 0.44% | 182,850 | 769.10M |
| 110 | UHS | Universal Health Services, Inc. | 8.86B | 0.17% | 109,293 | 17.76B |
| 111 | TEM | Tempus AI, Inc. | 8.79B | -1.25% | 2,062,971 | 1.36B |
| 112 | ENSG | The Ensign Group, Inc. | 8.62B | 1.07% | 393,192 | 5.27B |
| 113 | OSCR | Oscar Health, Inc. | 8.46B | -2.82% | 1,448,505 | 13.30B |
| 114 | TECH | Bio-Techne Corporation | 8.44B | -0.17% | 279,722 | 1.21B |
| 115 | BRKR | Bruker Corporation | 8.33B | -0.89% | 828,631 | 3.46B |
| 116 | HALO | Halozyme Therapeutics, Inc. | 8.24B | -1.75% | 243,587 | 1.51B |
| 117 | ABVX | ABIVAX Sociรฉtรฉ Anonyme | 7.82B | -2.25% | 352,325 | 5.67M |
| 118 | BIO | Bio-Rad Laboratories, Inc. | 7.68B | -1.87% | 34,257 | 2.59B |
| 119 | QGEN | Qiagen N.V. | 7.67B | -0.94% | 923,742 | 2.10B |
| 120 | IBRX | ImmunityBio, Inc. | 7.61B | 0.97% | 2,443,031 | 140.98M |
| 121 | ALKS | Alkermes plc | 7.56B | 0.96% | 328,733 | 1.56B |
| 122 | RGEN | Repligen Corporation | 7.56B | 0.49% | 224,363 | 763.34M |
| 123 | ATR | AptarGroup, Inc. | 7.48B | 0.60% | 90,610 | 3.87B |
| 124 | GKOS | Glaukos Corporation | 7.48B | 2.50% | 148,296 | 551.35M |
| 125 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | 6.73% | 156,977 | 7.46M |
| 126 | HQY | HealthEquity, Inc. | 7.31B | -1.78% | 118,091 | 1.34B |
| 127 | KYMR | Kymera Therapeutics, Inc. | 7.21B | 5.72% | 180,244 | 51.48M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 7.17B | 2.22% | 219,508 | - |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 7.15B | 1.28% | 186,810 | 74.06M |
| 130 | TGTX | TG Therapeutics, Inc. | 7.01B | 2.93% | 562,814 | 700.35M |
| 131 | PCVX | Vaxcyte, Inc. | 6.94B | 1.56% | 370,750 | - |
| 132 | IMVT | Immunovant, Inc. | 6.91B | 2.40% | 351,099 | - |
| 133 | APGE | Apogee Therapeutics, Inc. | 6.81B | 1.56% | 156,063 | - |
| 134 | LNTH | Lantheus Holdings, Inc. | 6.76B | -0.48% | 154,805 | 1.55B |
| 135 | LEGN | Legend Biotech Corporation | 6.56B | -2.70% | 479,748 | 1.14B |
| 136 | AVTR | Avantor, Inc. | 6.55B | -0.72% | 2,417,050 | 6.55B |
| 137 | LQDA | Liquidia Corporation | 6.39B | 0.30% | 571,316 | 288.07M |
| 138 | HIMS | Hims & Hers Health, Inc. | 6.30B | -5.78% | 8,139,016 | 2.37B |
| 139 | PTCT | PTC Therapeutics, Inc. | 6.28B | 1.27% | 279,833 | 827.11M |
| 140 | GRFS | Grifols, S.A. | 6.23B | 1.40% | 154,358 | 8.58B |
| 141 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 1.92% | 149,856 | 569.61M |
| 142 | CNTA | Centessa Pharmaceuticals plc | 6.14B | -0.15% | 268,403 | 15.00M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.12B | 1.94% | 87,838 | 217.17M |
| 144 | TFX | Teleflex Incorporated | 5.79B | 1.08% | 106,039 | 2.13B |
| 145 | COGT | Cogent Biosciences, Inc. | 5.72B | 2.51% | 336,306 | - |
| 146 | PACS | PACS Group, Inc. | 5.70B | 3.54% | 199,548 | 5.43B |
| 147 | CHE | Chemed Corporation | 5.52B | -0.72% | 41,868 | 2.54B |
| 148 | SRRK | Scholar Rock Holding Corporation | 5.47B | 2.22% | 418,191 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 5.41B | -0.72% | 58,957 | 5.21B |
| 150 | BLTE | Belite Bio, Inc | 5.38B | -0.04% | 47,549 | - |
| 151 | CGON | CG Oncology, Inc. | 5.30B | 4.32% | 212,004 | 5.07M |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.18B | -0.58% | 895,517 | 3.05B |
| 153 | LGND | Ligand Pharmaceuticals Incorporated | 5.12B | 0.33% | 67,210 | 274.48M |
| 154 | XENE | Xenon Pharmaceuticals Inc. | 5.12B | 1.44% | 205,713 | 7.50M |
| 155 | CAI | Caris Life Sciences, Inc. | 5.11B | 0.39% | 652,913 | 907.29M |
| 156 | HNGE | Hinge Health, Inc. | 5.05B | 0.86% | 301,172 | 646.34M |
| 157 | CRSP | CRISPR Therapeutics AG | 4.90B | 1.15% | 348,427 | 4.10M |
| 158 | TVTX | Travere Therapeutics, Inc. | 4.84B | 6.52% | 859,744 | 536.20M |
| 159 | TWST | Twist Bioscience Corporation | 4.79B | 3.86% | 890,851 | 409.48M |
| 160 | STVN | Stevanato Group S.p.A. | 4.71B | -0.17% | 256,811 | 1.39B |
| 161 | RDNT | RadNet, Inc. | 4.65B | 1.53% | 79,346 | 2.14B |
| 162 | BLLN | BillionToOne, Inc. | 4.64B | 1.30% | 229,958 | 354.54M |
| 163 | SHC | Sotera Health Company | 4.64B | -0.79% | 437,615 | 1.19B |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 4.44B | 6.34% | 566,068 | 1.34M |
| 165 | ERAS | Erasca, Inc. | 4.39B | 0.86% | 583,348 | - |
| 166 | LIVN | LivaNova PLC | 4.35B | -1.05% | 100,989 | 1.43B |
| 167 | MMED | MiniMed Group, Inc. | 4.33B | -0.26% | 300,731 | 3.10B |
| 168 | TNGX | Tango Therapeutics, Inc. | 4.33B | 0.40% | 2,234,699 | 56.99M |
| 169 | CELC | Celcuity Inc. | 4.29B | -1.66% | 328,945 | - |
| 170 | ORKA | Oruka Therapeutics, Inc. | 4.24B | 2.64% | 246,040 | - |
| 171 | ALHC | Alignment Healthcare, Inc. | 4.15B | -0.84% | 1,232,750 | 4.26B |
| 172 | MANE | Veradermics, Incorporated | 4.09B | 3.61% | 109,055 | - |
| 173 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.03B | 1.57% | 87,845 | 754.05M |
| 174 | NVST | Envista Holdings Corporation | 4.01B | 0.65% | 859,874 | 2.81B |
| 175 | MMSI | Merit Medical Systems, Inc. | 3.99B | -0.06% | 135,144 | 1.54B |
| 176 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | 0.06% | 261,855 | 596.96M |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 3.76B | 3.12% | 281,077 | - |
| 178 | VCYT | Veracyte, Inc. | 3.75B | -0.89% | 214,335 | 541.74M |
| 179 | DOCS | Doximity, Inc. | 3.70B | 0.95% | 548,679 | 644.86M |
| 180 | IRTC | iRhythm Holdings, Inc. | 3.69B | -0.43% | 48,275 | 787.85M |
| 181 | TXG | 10x Genomics, Inc. | 3.68B | -0.28% | 556,969 | 638.78M |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.67B | 0.14% | 222,086 | 1.10B |
| 183 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.62B | 2.49% | 355,799 | 18.07M |
| 184 | NAMS | NewAmsterdam Pharma Company N.V. | 3.61B | 2.05% | 260,977 | 22.57M |
| 185 | CON | Concentra Group Holdings Parent, Inc. | 3.58B | 2.79% | 412,466 | 2.23B |
| 186 | PBLS | Parabilis Medicines, Inc. | 3.57B | -0.26% | 320,363 | - |
| 187 | WAY | Waystar Holding Corp. | 3.56B | 0.49% | 418,750 | 1.16B |
| 188 | ICUI | ICU Medical, Inc. | 3.56B | -0.41% | 63,979 | 2.16B |
| 189 | HAE | Haemonetics Corporation | 3.54B | -2.45% | 351,831 | 1.33B |
| 190 | OGN | Organon & Co. | 3.53B | 0.04% | 318,610 | 6.16B |
| 191 | DNLI | Denali Therapeutics Inc. | 3.51B | 5.11% | 630,388 | - |
| 192 | VKTX | Viking Therapeutics, Inc. | 3.38B | 1.71% | 330,344 | - |
| 193 | LFST | LifeStance Health Group, Inc. | 3.30B | -1.16% | 808,630 | 1.49B |
| 194 | OPCH | Option Care Health, Inc. | 3.28B | 0.43% | 651,229 | 5.67B |
| 195 | WRBY | Warby Parker Inc. | 3.27B | 2.94% | 688,698 | 890.57M |
| 196 | RLAY | Relay Therapeutics, Inc. | 3.26B | 4.95% | 591,340 | 10.68M |
| 197 | TLX | Telix Pharmaceuticals Limited | 3.23B | 1.27% | 160,718 | 803.79M |
| 198 | BKD | Brookdale Senior Living Inc. | 3.15B | 1.93% | 715,209 | 3.00B |
| 199 | ITGR | Integer Holdings Corporation | 3.13B | -0.05% | 26,196 | 1.86B |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 3.11B | 1.22% | 420,186 | 415.62M |
| 201 | NHC | National HealthCare Corporation | 3.10B | 1.28% | 54,961 | 1.53B |
| 202 | GPCR | Structure Therapeutics Inc. | 3.07B | -0.16% | 164,650 | - |
| 203 | DYN | Dyne Therapeutics, Inc. | 3.05B | 2.67% | 176,859 | - |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.03B | 3.24% | 454,365 | 236.00M |
| 205 | BEAM | Beam Therapeutics Inc. | 2.98B | 1.70% | 524,323 | 164.01M |
| 206 | PRVA | Privia Health Group, Inc. | 2.96B | 0.51% | 176,257 | 2.25B |
| 207 | ALMS | Alumis Inc. | 2.95B | 10.81% | 352,212 | 8.40M |
| 208 | ADPT | Adaptive Biotechnologies Corporation | 2.86B | -4.64% | 1,246,086 | 295.41M |
| 209 | GRDN | Guardian Pharmacy Services, Inc. | 2.76B | 1.22% | 32,350 | 1.46B |
| 210 | HTFL | HeartFlow, Inc. | 2.75B | 4.14% | 631,683 | 191.42M |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.74B | 11.48% | 3,185,417 | - |
| 212 | DFTX | Definium Therapeutics, Inc. | 2.71B | 2.99% | 768,611 | - |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.70B | 0.28% | 66,623 | 535.08M |
| 214 | IRON | Disc Medicine, Inc. | 2.66B | 2.38% | 51,607 | - |
| 215 | SUPN | Supernus Pharmaceuticals, Inc. | 2.60B | -1.73% | 188,132 | 776.83M |
| 216 | GRAL | GRAIL, Inc. | 2.60B | 0.60% | 112,654 | 156.12M |
| 217 | IDYA | IDEAYA Biosciences, Inc. | 2.58B | 1.98% | 159,548 | 225.27M |
| 218 | KLRA | Kailera Therapeutics, Inc. | 2.54B | 0.31% | 107,867 | - |
| 219 | TMDX | TransMedics Group, Inc. | 2.53B | -0.38% | 283,952 | 635.89M |
| 220 | VERA | Vera Therapeutics, Inc. | 2.51B | 3.92% | 229,655 | - |
| 221 | CLOV | Clover Health Investments, Corp. | 2.49B | -3.47% | 3,894,911 | 2.21B |
| 222 | ESTA | Establishment Labs Holdings Inc. | 2.48B | -0.95% | 206,608 | 229.58M |
| 223 | RARE | Ultragenyx Pharmaceutical Inc. | 2.42B | 2.69% | 278,685 | 670.00M |
| 224 | CLDX | Celldex Therapeutics, Inc. | 2.40B | 2.27% | 86,466 | 865.00K |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.30B | 0.56% | 226,187 | 3.37B |
| 226 | AXGN | Axogen, Inc. | 2.30B | 2.05% | 290,936 | 238.11M |
| 227 | PHVS | Pharvaris N.V. | 2.26B | 0.85% | 52,988 | - |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | 0.36% | 74,008 | 1.09B |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.21B | 2.12% | 513,650 | 885.72M |
| 230 | KOD | Kodiak Sciences Inc. | 2.18B | 2.99% | 218,386 | - |
| 231 | IMNM | Immunome, Inc. | 2.14B | 2.72% | 486,716 | 4.02M |
| 232 | LMAT | LeMaitre Vascular, Inc. | 2.11B | 0.08% | 56,353 | 256.28M |
| 233 | NVCR | NovoCure Limited | 2.08B | 1.50% | 201,399 | 674.41M |
| 234 | TRVI | Trevi Therapeutics, Inc. | 2.07B | 8.40% | 443,323 | - |
| 235 | SEM | Select Medical Holdings Corporation | 2.06B | -0.06% | 362,411 | 5.52B |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.20% | 253,492 | 298.30M |
| 237 | HRMY | Harmony Biosciences Holdings, Inc. | 2.06B | 0.99% | 97,270 | 899.11M |
| 238 | XRAY | DENTSPLY SIRONA Inc. | 2.05B | 0.89% | 849,491 | 3.68B |
| 239 | NKTR | Nektar Therapeutics | 2.04B | 1.79% | 163,066 | 55.63M |
| 240 | PGNY | Progyny, Inc. | 2.03B | 1.17% | 351,039 | 1.29B |
| 241 | NEOG | Neogen Corporation | 2.02B | 0.27% | 276,107 | 870.56M |
| 242 | SGRY | Surgery Partners, Inc. | 1.97B | 1.81% | 251,139 | 3.34B |
| 243 | ASTH | Astrana Health, Inc. | 1.97B | -0.35% | 152,686 | 3.53B |
| 244 | VCEL | Vericel Corporation | 1.96B | -0.26% | 83,849 | 292.09M |
| 245 | MD | Pediatrix Medical Group, Inc. | 1.95B | 0.81% | 128,343 | 1.93B |
| 246 | ZLAB | Zai Lab Limited | 1.94B | -1.87% | 427,218 | 453.28M |
| 247 | HCM | HUTCHMED (China) Limited | 1.94B | 2.62% | 12,590 | 548.51M |
| 248 | MLYS | Mineralys Therapeutics, Inc. | 1.94B | -1.75% | 270,966 | - |
| 249 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 1.15% | 628,305 | 52.04M |
| 250 | BHC | Bausch Health Companies Inc. | 1.92B | -0.39% | 362,432 | 10.53B |
| 251 | ADMA | ADMA Biologics, Inc. | 1.91B | -0.78% | 846,839 | 509.86M |
| 252 | NRIX | Nurix Therapeutics, Inc. | 1.89B | 7.54% | 1,217,945 | 71.78M |
| 253 | STOK | Stoke Therapeutics, Inc. | 1.89B | 3.24% | 154,104 | 32.08M |
| 254 | LKFT | Lakefront Biotherapeutics NV | 1.89B | 0.28% | 47,906 | 1.20B |
| 255 | AGL | agilon health, inc. | 1.88B | -2.77% | 115,720 | 5.82B |
| 256 | UFPT | UFP Technologies, Inc. | 1.87B | 1.36% | 137,246 | 608.85M |
| 257 | PLSE | Pulse Biosciences, Inc. | 1.87B | 0.45% | 148,337 | 751.00K |
| 258 | IOVA | Iovance Biotherapeutics, Inc. | 1.85B | 4.80% | 4,186,027 | 285.61M |
| 259 | WGS | GeneDx Holdings Corp. | 1.85B | 2.02% | 626,443 | 442.68M |
| 260 | VRDN | Viridian Therapeutics, Inc. | 1.84B | 3.28% | 439,206 | 70.92M |
| 261 | RAPP | Rapport Therapeutics, Inc. | 1.83B | 8.52% | 55,524 | 20.00M |
| 262 | BHVN | Biohaven Ltd. | 1.80B | 5.19% | 754,085 | - |
| 263 | QURE | uniQure N.V. | 1.77B | 4.74% | 472,990 | 18.09M |
| 264 | MESO | Mesoblast Limited | 1.77B | -0.71% | 39,546 | 65.38M |
| 265 | AGIO | Agios Pharmaceuticals, Inc. | 1.76B | 3.17% | 262,660 | 66.05M |
| 266 | NUVB | Nuvation Bio Inc. | 1.75B | 5.88% | 3,202,206 | 143.05M |
| 267 | ADUS | Addus HomeCare Corporation | 1.74B | 2.02% | 36,902 | 1.45B |
| 268 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | - | 55,264 | 923.71M |
| 269 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 3.02% | 6,602,584 | 66.41M |
| 270 | OMCL | Omnicell, Inc. | 1.72B | 0.03% | 181,986 | 1.23B |
| 271 | NTLA | Intellia Therapeutics, Inc. | 1.72B | -0.57% | 2,468,440 | 66.09M |
| 272 | ZYME | Zymeworks Inc. | 1.71B | 1.98% | 82,911 | 81.26M |
| 273 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | 6.45% | 834,681 | 7.47M |
| 274 | NBTX | Nanobiotix S.A. | 1.69B | 0.34% | 35,936 | 38.27M |
| 275 | INVA | Innoviva, Inc. | 1.67B | 0.67% | 121,205 | 420.69M |
| 276 | SION | Sionna Therapeutics, Inc. | 1.66B | 2.00% | 46,926 | - |
| 277 | GENB | Generate Biomedicines, Inc. | 1.66B | 0.08% | 223,433 | 30.30M |
| 278 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.64B | 6.33% | 510,452 | -665.00K |
| 279 | CMPS | COMPASS Pathways plc | 1.64B | 6.57% | 1,313,311 | - |
| 280 | AAPG | Ascentage Pharma Group International | 1.64B | 3.16% | 9,480 | 82.08M |
| 281 | SNDA | Sonida Senior Living, Inc. | 1.64B | -0.02% | 135,911 | 367.34M |
| 282 | ABCL | AbCellera Biologics Inc. | 1.63B | 1.23% | 793,202 | 79.21M |
| 283 | SRPT | Sarepta Therapeutics, Inc. | 1.62B | 2.53% | 621,627 | 2.18B |
| 284 | TYRA | Tyra Biosciences, Inc. | 1.62B | 6.61% | 380,113 | - |
| 285 | ANAB | AnaptysBio, Inc. | 1.62B | 2.66% | 103,490 | 232.39M |
| 286 | MBX | MBX Biosciences, Inc. | 1.62B | -8.72% | 1,109,830 | - |
| 287 | PGEN | Precigen, Inc. | 1.61B | -0.22% | 2,268,009 | 31.60M |
| 288 | SNDX | Syndax Pharmaceuticals, Inc. | 1.61B | 1.23% | 336,881 | 217.17M |
| 289 | SEPN | Septerna, Inc. | 1.59B | 3.79% | 100,815 | 72.26M |
| 290 | FTRE | Fortrea Holdings Inc. | 1.59B | -0.59% | 350,493 | 2.71B |
| 291 | AVAH | Aveanna Healthcare Holdings Inc. | 1.55B | 1.50% | 306,490 | 2.52B |
| 292 | BFLY | Butterfly Network, Inc. | 1.54B | 3.87% | 2,087,261 | 102.92M |
| 293 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | 6.02% | 415,592 | 42.95M |
| 294 | PVLA | Palvella Therapeutics, Inc. | 1.53B | 0.11% | 149,240 | - |
| 295 | ALMR | Alamar Biosciences, Inc. | 1.52B | -0.86% | 58,333 | 87.16M |
| 296 | PRGO | Perrigo Company plc | 1.52B | 0.92% | 915,631 | 4.18B |
| 297 | HCSG | Healthcare Services Group, Inc. | 1.51B | 2.09% | 119,205 | 1.85B |
| 298 | URGN | UroGen Pharma Ltd. | 1.51B | 5.15% | 203,365 | 140.49M |
| 299 | GHRS | GH Research PLC | 1.51B | 6.44% | 45,144 | - |
| 300 | PRCT | PROCEPT BioRobotics Corporation | 1.50B | -5.09% | 247,872 | 322.02M |
| 301 | IMCR | Immunocore Holdings plc | 1.49B | 2.50% | 35,300 | 412.81M |
| 302 | NVAX | Novavax, Inc. | 1.49B | 0.22% | 1,026,473 | 596.34M |
| 303 | VIR | Vir Biotechnology, Inc. | 1.49B | 3.40% | 344,210 | 65.50M |
| 304 | SLS | SELLAS Life Sciences Group, Inc. | 1.48B | 2.71% | 1,656,561 | - |
| 305 | CAPR | Capricor Therapeutics, Inc. | 1.48B | 1.80% | 244,343 | 11.13M |
| 306 | NEO | NeoGenomics, Inc. | 1.47B | -1.31% | 329,657 | 745.97M |
| 307 | HROW | Harrow, Inc. | 1.47B | 4.91% | 278,900 | 268.68M |
| 308 | ARDX | Ardelyx, Inc. | 1.46B | 1.73% | 668,548 | 427.68M |
| 309 | ATAI | AtaiBeckley Inc. | 1.45B | 3.95% | 1,635,655 | 3.49M |
| 310 | ATRC | AtriCure, Inc. | 1.45B | 0.86% | 113,683 | 552.16M |
| 311 | BCAX | Bicara Therapeutics Inc. | 1.44B | 2.91% | 96,227 | - |
| 312 | AVBP | ArriVent BioPharma, Inc. | 1.44B | 2.09% | 145,837 | - |
| 313 | STAA | STAAR Surgical Company | 1.43B | -0.43% | 86,027 | 290.38M |
| 314 | MAZE | Maze Therapeutics, Inc. | 1.38B | 3.24% | 220,713 | 20.00M |
| 315 | INBX | Inhibrx Biosciences, Inc. | 1.38B | 0.22% | 163,896 | 1.30M |
| 316 | AHCO | AdaptHealth Corp. | 1.36B | 1.39% | 189,679 | 3.29B |
| 317 | MLTX | MoonLake Immunotherapeutics | 1.36B | 4.25% | 239,155 | - |
| 318 | IART | Integra LifeSciences Holdings Corporation | 1.36B | -0.03% | 91,453 | 1.64B |
| 319 | SVRA | Savara Inc. | 1.36B | 1.71% | 411,553 | - |
| 320 | ARDT | Ardent Health, Inc. | 1.35B | -2.48% | 131,374 | 6.43B |
| 321 | DMRA | Damora Therapeutics, Inc. | 1.34B | 2.13% | 60,156 | - |
| 322 | MPLT | MapLight Therapeutics, Inc. | 1.33B | -3.36% | 100,473 | - |
| 323 | ALVO | Alvotech | 1.33B | 0.95% | 179,543 | 562.04M |
| 324 | BLFS | BioLife Solutions, Inc. | 1.32B | 1.47% | 271,974 | 101.66M |
| 325 | TDOC | Teladoc Health, Inc. | 1.31B | -0.41% | 841,142 | 2.51B |
| 326 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.30B | -3.45% | 719,948 | 204.73M |
| 327 | PAHC | Phibro Animal Health Corporation | 1.30B | 2.24% | 36,014 | 1.50B |
| 328 | IMTX | Immatics N.V. | 1.28B | 3.64% | 122,658 | 43.00M |
| 329 | INNV | InnovAge Holding Corp. | 1.28B | 3.06% | 104,750 | 949.17M |
| 330 | ATEC | Alphatec Holdings, Inc. | 1.26B | 1.11% | 393,633 | 787.08M |
| 331 | INSP | Inspire Medical Systems, Inc. | 1.25B | 2.29% | 239,070 | 915.25M |
| 332 | ZBIO | Zenas BioPharma, Inc. | 1.25B | 11.43% | 334,965 | 10.00M |
| 333 | ENOV | Enovis Corporation | 1.24B | 2.18% | 217,451 | 2.28B |
| 334 | KMTS | Kestra Medical Technologies, Ltd. | 1.23B | 4.47% | 212,872 | 83.72M |
| 335 | IRMD | IRADIMED CORPORATION | 1.22B | -1.18% | 98,590 | 86.28M |
| 336 | CDNA | CareDx, Inc. | 1.22B | -0.59% | 101,640 | 412.82M |
| 337 | AMN | AMN Healthcare Services, Inc. | 1.21B | 1.53% | 142,458 | 3.42B |
| 338 | AKTS | Aktis Oncology, Inc. | 1.21B | 12.08% | 270,186 | 8.28M |
| 339 | AVLN | Avalyn Pharma Inc. | 1.20B | 2.44% | 47,438 | - |
| 340 | XERS | Xeris Biopharma Holdings, Inc. | 1.20B | 0.29% | 566,541 | 314.85M |
| 341 | AHG | Akso Health Group | 1.17B | - | 6,983 | 14.84M |
| 342 | AVNS | Avanos Medical, Inc. | 1.17B | 0.02% | 82,941 | 715.90M |
| 343 | COAG | Hemab Therapeutics Holdings, Inc. | 1.16B | -2.45% | 49,609 | - |
| 344 | MNKD | MannKind Corporation | 1.15B | -0.53% | 1,417,976 | 360.78M |
| 345 | PNTG | The Pennant Group, Inc. | 1.14B | 0.40% | 40,374 | 1.02B |
| 346 | WVE | Wave Life Sciences Ltd. | 1.14B | 2.24% | 650,792 | 71.80M |
| 347 | TNDM | Tandem Diabetes Care, Inc. | 1.13B | 4.43% | 568,881 | 1.03B |
| 348 | COLL | Collegium Pharmaceutical, Inc. | 1.12B | 0.55% | 43,392 | 796.33M |
| 349 | OPK | OPKO Health, Inc. | 1.09B | -0.69% | 791,879 | 581.12M |
| 350 | SDGR | Schrรถdinger, Inc. | 1.09B | -0.48% | 260,882 | 254.91M |
| 351 | EYPT | EyePoint, Inc. | 1.07B | 2.24% | 478,709 | 7.61M |
| 352 | ABSI | Absci Corporation | 1.06B | 4.92% | 1,967,801 | 1.84M |
| 353 | AZTA | Azenta, Inc. | 1.06B | 2.54% | 96,253 | 596.48M |
| 354 | CNMD | CONMED Corporation | 1.06B | 2.21% | 93,497 | 1.37B |
| 355 | OMDA | Omada Health, Inc. | 1.04B | -1.75% | 157,105 | 283.30M |
| 356 | CRON | Cronos Group Inc. | 1.03B | -0.91% | 245,108 | 159.54M |
| 357 | NUTX | Nutex Health Inc. | 1.03B | 1.43% | 29,083 | 879.95M |
| 358 | CRVS | Corvus Pharmaceuticals, Inc. | 1.02B | 4.91% | 265,606 | - |
| 359 | USPH | U.S. Physical Therapy, Inc. | 1.02B | 1.47% | 50,971 | 787.69M |
| 360 | PSNL | Personalis, Inc. | 1.01B | 2.76% | 762,461 | 64.52M |
| 361 | AORT | Artivion, Inc. | 1.01B | 0.53% | 87,120 | 458.69M |
| 362 | SPRY | ARS Pharmaceuticals, Inc. | 980.12M | 2.92% | 565,495 | 98.99M |
| 363 | QDEL | QuidelOrtho Corporation | 971.72M | 1.14% | 224,211 | 2.66B |
| 364 | SPTX | Seaport Therapeutics, Inc. | 971.47M | 3.39% | 35,158 | - |
| 365 | LMRI | Lumexa Imaging Holdings, Inc. | 964.65M | 5.46% | 129,755 | 1.03B |
| 366 | DBVT | DBV Technologies S.A. | 962.97M | 5.26% | 48,066 | 5.74M |
| 367 | EVO | Evotec SE | 953.68M | 0.74% | 2,691 | 859.03M |
| 368 | JBIO | Jade Biosciences, Inc. | 931.36M | -2.43% | 326,245 | - |
| 369 | XNCR | Xencor, Inc. | 923.80M | 3.06% | 131,087 | 97.36M |
| 370 | PCRX | Pacira BioSciences, Inc. | 917.79M | -0.15% | 103,135 | 734.86M |
| 371 | DRTS | Alpha Tau Medical Ltd. | 911.68M | 4.44% | 418,888 | - |
| 372 | MGTX | MeiraGTx Holdings plc | 897.39M | 0.94% | 112,293 | 79.76M |
| 373 | PHAR | Pharming Group N.V. | 894.01M | 0.62% | 6,036 | 369.49M |
| 374 | AVR | Anteris Technologies Global Corp. | 893.35M | -0.32% | 182,776 | 1.85M |
| 375 | GDRX | GoodRx Holdings, Inc. | 890.72M | - | 270,925 | 787.89M |
| 376 | AMPH | Amphastar Pharmaceuticals, Inc. | 889.80M | -1.70% | 85,267 | 720.53M |
| 377 | LXRX | Lexicon Pharmaceuticals, Inc. | 888.39M | 5.82% | 1,226,316 | 69.64M |
| 378 | ETON | Eton Pharmaceuticals, Inc. | 874.36M | -0.59% | 56,376 | 86.93M |
| 379 | TALK | Talkspace, Inc. | 872.74M | - | 304,186 | 238.37M |
| 380 | OLMA | Olema Pharmaceuticals, Inc. | 864.74M | 1.54% | 714,200 | - |
| 381 | ORIC | ORIC Pharmaceuticals, Inc. | 858.16M | 6.01% | 546,874 | - |
| 382 | INMD | InMode Ltd. | 855.98M | 0.15% | 192,505 | 374.64M |
| 383 | TBPH | Theravance Biopharma, Inc. | 855.78M | 0.67% | 83,330 | 109.78M |
| 384 | ABUS | Arbutus Biopharma Corporation | 851.39M | 0.47% | 300,646 | 191.45M |
| 385 | JANX | Janux Therapeutics, Inc. | 840.36M | 0.88% | 243,787 | 13.73M |
| 386 | PHAT | Phathom Pharmaceuticals, Inc. | 837.19M | 2.63% | 131,124 | 204.89M |
| 387 | LBRX | LB Pharmaceuticals Inc | 832.05M | 1.66% | 14,000 | - |
| 388 | ODTX | Odyssey Therapeutics, Inc. | 827.91M | 4.40% | 34,193 | 2.98M |
| 389 | CERT | Certara, Inc. | 822.94M | 0.38% | 1,079,224 | 419.75M |
| 390 | KURA | Kura Oncology, Inc. | 814.06M | 3.50% | 319,255 | 71.64M |
| 391 | ESPR | Esperion Therapeutics, Inc. | 812.20M | 0.16% | 9,103,252 | 418.24M |
| 392 | CGEM | Cullinan Therapeutics, Inc. | 810.63M | 1.62% | 197,309 | - |
| 393 | BIOA | BioAge Labs, Inc. | 800.59M | 9.48% | 135,400 | 10.32M |
| 394 | IVA | Inventiva S.A. | 792.25M | 1.32% | 289,274 | 7.94M |
| 395 | VOR | Vor Biopharma Inc. | 787.86M | 3.19% | 183,507 | - |
| 396 | ANNX | Annexon, Inc. | 786.44M | 2.13% | 1,555,872 | - |
| 397 | ANRO | Alto Neuroscience, Inc. | 786.28M | 4.55% | 82,998 | - |
| 398 | ZVRA | Zevra Therapeutics, Inc. | 783.87M | 2.24% | 691,076 | 122.29M |
| 399 | SANA | Sana Biotechnology, Inc. | 779.22M | 1.08% | 544,889 | - |
| 400 | NNNN | Anbio Biotechnology | 776.44M | 7.60% | 10,980 | 8.65M |
| 401 | AVTX | Avalo Therapeutics, Inc. | 775.87M | 7.97% | 413,691 | 59.00K |
| 402 | EVMN | Evommune, Inc. | 775.12M | 4.01% | 246,859 | 10.00M |
| 403 | HSTM | HealthStream, Inc. | 773.33M | 0.95% | 25,757 | 311.78M |
| 404 | REPL | Replimune Group, Inc. | 748.52M | 5.16% | 651,644 | - |
| 405 | GERN | Geron Corporation | 740.96M | 1.32% | 3,502,396 | 196.12M |
| 406 | BVS | Bioventus Inc. | 725.92M | 0.12% | 103,263 | 576.30M |
| 407 | RLMD | Relmada Therapeutics, Inc. | 724.79M | 5.98% | 272,833 | - |
| 408 | SLDB | Solid Biosciences Inc. | 724.59M | 1.94% | 687,070 | - |
| 409 | AURA | Aura Biosciences, Inc. | 714.74M | 4.35% | 351,438 | - |
| 410 | TENX | Tenax Therapeutics, Inc. | 709.19M | 12.26% | 751,073 | - |
| 411 | SSII | SS Innovations International, Inc. | 700.46M | -0.85% | 13,640 | 48.47M |
| 412 | CBLL | CeriBell, Inc. | 700.04M | 1.65% | 64,611 | 95.07M |
| 413 | CRMD | CorMedix Inc. | 699.01M | -0.56% | 267,337 | 400.05M |
| 414 | GMRS | GMR Solutions Inc. | 696.21M | -0.15% | 178,064 | 5.83B |
| 415 | OCS | Oculis Holding AG | 692.65M | 4.27% | 119,437 | 1.40M |
| 416 | DSGN | Design Therapeutics, Inc. | 685.78M | 4.27% | 125,661 | - |
| 417 | SIBN | SI-BONE, Inc. | 682.54M | 1.65% | 60,126 | 206.22M |
| 418 | CTMX | CytomX Therapeutics, Inc. | 659.64M | 1.68% | 537,750 | 35.54M |
| 419 | ALLO | Allogene Therapeutics, Inc. | 659.25M | 1.60% | 1,498,077 | 22.00K |
| 420 | VRXA | VERAXA Biotech AG | 657.80M | 4.88% | 10,502 | - |
| 421 | BBNX | Beta Bionics, Inc. | 655.95M | 0.20% | 374,796 | 110.24M |
| 422 | CSTL | Castle Biosciences, Inc. | 633.29M | -0.62% | 36,160 | 339.92M |
| 423 | CADL | Candel Therapeutics, Inc. | 630.86M | 5.51% | 635,441 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 627.09M | 2.75% | 235,121 | 8.37M |
| 425 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 624.84M | 4.56% | 54,826 | - |
| 426 | OMER | Omeros Corporation | 623.15M | -15.42% | 5,026,103 | 9.89M |
| 427 | CBIO | Crescent Biopharma, Inc. | 621.38M | 1.96% | 50,997 | 11.88M |
| 428 | SGP | SpyGlass Pharma, Inc. | 620.06M | 2.54% | 13,133 | - |
| 429 | RIGL | Rigel Pharmaceuticals, Inc. | 619.26M | 4.33% | 70,279 | 299.77M |
| 430 | TRAX | First Tracks Biotherapeutics, Inc. | 610.27M | 2.70% | 142,584 | - |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 608.25M | 1.79% | 670,972 | 361.51M |
| 432 | TLRY | Tilray Brands, Inc. | 601.19M | -1.56% | 1,314,245 | 858.28M |
| 433 | DRUG | Bright Minds Biosciences Inc. | 601.15M | -0.71% | 529,351 | - |
| 434 | TCMD | Tactile Systems Technology, Inc. | 599.09M | 0.80% | 21,688 | 343.52M |
| 435 | IMMX | Immix Biopharma, Inc. | 596.01M | 5.43% | 419,398 | - |
| 436 | ACHV | Achieve Life Sciences, Inc. | 588.24M | 3.80% | 359,188 | - |
| 437 | BWAY | BrainsWay Ltd. | 584.32M | 1.09% | 17,079 | 56.22M |
| 438 | PHR | Phreesia, Inc. | 561.87M | 0.44% | 204,309 | 495.59M |
| 439 | CTEV | Claritev Corporation | 556.01M | 1.83% | 20,845 | 978.76M |
| 440 | TECX | Tectonic Therapeutic, Inc. | 552.21M | -0.26% | 31,248 | - |
| 441 | CLYM | Climb Bio, Inc. | 552.20M | 5.96% | 279,122 | - |
| 442 | GYRE | Gyre Therapeutics, Inc. | 549.15M | -0.83% | 34,593 | 117.05M |
| 443 | MDXG | MiMedx Group, Inc. | 548.12M | -0.27% | 275,744 | 389.42M |
| 444 | NPCE | NeuroPace, Inc. | 542.43M | 0.44% | 24,918 | 99.53M |
| 445 | AQST | Aquestive Therapeutics, Inc. | 534.42M | 1.19% | 542,200 | 50.27M |
| 446 | EVH | Evolent Health, Inc. | 534.29M | 3.71% | 899,788 | 1.89B |
| 447 | FLGT | Fulgent Genetics, Inc. | 531.94M | -0.27% | 51,232 | 320.35M |
| 448 | DNA | Ginkgo Bioworks Holdings, Inc. | 531.41M | 1.69% | 198,885 | 151.40M |
| 449 | CERS | Cerus Corporation | 524.97M | 1.16% | 737,393 | 216.56M |
| 450 | TOI | The Oncology Institute, Inc. | 524.91M | 2.34% | 423,415 | 545.76M |
| 451 | XOMA | XOMA Royalty Corporation | 524.09M | -0.02% | 25,350 | 48.56M |
| 452 | ALT | Altimmune, Inc. | 512.44M | 1.74% | 600,211 | 36.00K |
| 453 | CTKB | Cytek Biosciences, Inc. | 511.40M | -1.49% | 597,560 | 204.17M |
| 454 | PRME | Prime Medicine, Inc. | 511.15M | 0.35% | 442,038 | 4.03M |
| 455 | PROK | ProKidney Corp. | 507.46M | 1.20% | 367,426 | 889.00K |
| 456 | ANGO | AngioDynamics, Inc. | 505.19M | 0.33% | 74,411 | 313.73M |
| 457 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 458 | KYTX | Kyverna Therapeutics, Inc. | 501.80M | 5.34% | 243,329 | - |
| 459 | ARVN | Arvinas, Inc. | 498.75M | 9.03% | 255,810 | 89.40M |
| 460 | AGMB | AgomAb Therapeutics NV | 496.42M | 2.02% | 26,404 | - |
| 461 | CABA | Cabaletta Bio, Inc. | 490.79M | - | 801,888 | - |
| 462 | EIKN | Eikon Therapeutics, Inc. | 489.95M | 6.22% | 103,000 | - |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 487.21M | 5.49% | 204,685 | 88.24M |
| 464 | SRTA | Strata Critical Medical, Inc. | 486.28M | 2.37% | 857,410 | 228.58M |
| 465 | VREX | Varex Imaging Corporation | 484.26M | 4.17% | 76,373 | 857.50M |
| 466 | VALN | Valneva SE | 483.84M | 1.32% | 6,278 | 180.25M |
| 467 | STRO | Sutro Biopharma, Inc. | 474.08M | 8.04% | 47,186 | 99.61M |
| 468 | KIDS | OrthoPediatrics Corp. | 469.78M | 2.58% | 6,531 | 243.30M |
| 469 | ASMB | Assembly Biosciences, Inc. | 466.30M | 4.44% | 57,022 | 71.10M |
| 470 | NGNE | Neurogene Inc. | 462.84M | 1.00% | 44,120 | 925.00K |
| 471 | CCCC | C4 Therapeutics, Inc. | 462.72M | 8.14% | 1,517,054 | 34.86M |
| 472 | CTNM | Contineum Therapeutics, Inc. | 462.10M | 4.22% | 31,002 | - |
| 473 | EOLS | Evolus, Inc. | 451.76M | 5.38% | 236,951 | 301.79M |
| 474 | PRLD | Prelude Therapeutics Incorporated | 445.31M | 9.25% | 149,698 | 16.72M |
| 475 | PRTA | Prothena Corporation plc | 440.29M | 1.82% | 94,029 | 57.94M |
| 476 | FBRX | Forte Biosciences, Inc. | 439.11M | 3.28% | 54,085 | - |
| 477 | RZLT | Rezolute, Inc. | 438.76M | 8.81% | 444,944 | - |
| 478 | WEAV | Weave Communications, Inc. | 436.82M | 0.55% | 253,000 | 248.72M |
| 479 | OVID | Ovid Therapeutics Inc. | 436.74M | 5.88% | 649,050 | 7.12M |
| 480 | NRC | NRC Health | 436.09M | 2.98% | 21,657 | 138.64M |
| 481 | EBS | Emergent BioSolutions Inc. | 434.70M | 0.42% | 159,456 | 676.80M |
| 482 | AUTL | Autolus Therapeutics plc | 433.81M | 4.49% | 501,266 | 92.62M |
| 483 | PACB | Pacific Biosciences of California, Inc. | 423.97M | 1.11% | 1,693,820 | 160.03M |
| 484 | KMDA | Kamada Ltd. | 420.42M | 0.27% | 5,383 | 181.68M |
| 485 | ANL | Adlai Nortye Ltd. | 419.60M | 2.84% | 20,784 | 5.00M |
| 486 | CYH | Community Health Systems, Inc. | 418.55M | 1.31% | 426,502 | 12.29B |
| 487 | MYGN | Myriad Genetics, Inc. | 417.46M | -4.54% | 268,203 | 829.00M |
| 488 | CLPT | ClearPoint Neuro, Inc. | 416.85M | 0.43% | 172,247 | 40.61M |
| 489 | OCGN | Ocugen, Inc. | 416.38M | 0.82% | 1,154,427 | 4.47M |
| 490 | MOBI | Mobia Medical, Inc. | 413.24M | 1.38% | 77,934 | 32.04M |
| 491 | DCTH | Delcath Systems, Inc. | 411.15M | 1.23% | 117,769 | 90.44M |
| 492 | CCRN | Cross Country Healthcare, Inc. | 408.84M | -0.04% | 77,889 | 1.00B |
| 493 | MNPR | Monopar Therapeutics Inc. | 408.63M | 3.22% | 112,448 | - |
| 494 | VMD | Viemed Healthcare, Inc. | 406.41M | 1.74% | 48,798 | 286.57M |
| 495 | SGMT | Sagimet Biosciences Inc. | 406.33M | 2.33% | 170,063 | - |
| 496 | IPSC | Century Therapeutics, Inc. | 403.99M | - | 281,912 | 109.16M |
| 497 | ARTV | Artiva Biotherapeutics, Inc. | 403.77M | 3.88% | 485,925 | 251.00K |
| 498 | VTVT | vTv Therapeutics Inc. | 403.31M | 2.88% | 15,209 | 36.84M |
| 499 | SENS | Senseonics Holdings, Inc. | 395.70M | 3.41% | 149,795 | 35.26M |
| 500 | EPRX | Eupraxia Pharmaceuticals Inc. | 392.77M | 1.66% | 42,861 | - |